Effect of CPAP Treatment in Cognition in Adults With DS and OSA
Impact of Continuous Positive Airway Pressure Treatment on Cognitive Function in Adults With Down Syndrome With Obstructive Sleep Apnea
1 other identifier
interventional
60
1 country
1
Brief Summary
Adults with Down syndrome (DS) have a high prevalence of obstructive sleep apnea (OSA), which may worsen cognitive performance. In general population, continuous positive airway pressure (CPAP), the gold Standard treatment for OSA, partially reverses cognitive impairment secondary to OSA. CPAP treatment, however, is not regularly proposed in adults with DS and OSA. It is usually presumed both by caregivers and physicians, that DS patients will not tolerate or adapt to the treatment, and that they would not benefit much more from CPAP treatment. Therefore, data about the feasibility and impact of CPAP treatment on cognitive function in this population is lacking. The main objective of this study is to investigate cognitive performance in adults with DS and OSA, the corresponding functional brain changes and their reversibility with CPAP treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 28, 2019
CompletedStudy Start
First participant enrolled
December 1, 2019
CompletedFirst Posted
Study publicly available on registry
December 13, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2021
CompletedDecember 17, 2019
December 1, 2019
11 months
November 28, 2019
December 13, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Assessment of the changes on cognitive attentional tasks
psychomotor speed (in seconds) performing an attentional task
Baseline and after 6 months of treatment
Changes in cerebral functional connectivity
Significant probability maps (SPM) showing statistical changes on connectivity measures between sleep stages
Baseline and after 6 months of treatment
Study Arms (2)
Continuous Positive Airway Pressure(CPAP)
EXPERIMENTALPatients with CPAP treatment. Titration will be performed by polysomnography CPAP to determine the optimal treatment pressure. This group will also be instructed in sleep hygiene and dietary counseling Intervention: Device: CPAP Other: Conservative treatment for OSA
CONSERVATIVE TREATMENT for OSA
ACTIVE COMPARATORSleep hygiene and dietary counseling. Sleep hygiene (regular sleep schedule, physical exercise) and dietary counseling Intervention: Other: Conservative treatment for OSA
Interventions
CPAP treatment every night plus conservative treatment for OSA: sleep hygiene and dietary counseling
Conservative treatment for OSA: sleep hygiene and dietary counseling
Eligibility Criteria
You may qualify if:
- Subjects of both sexes with ages over 18 years old with DS.
- A good general health with adequate visual and auditory acuity will be required
- Understanding and accepting the study procedures and signing an informed consent (guardian and / or patient).
- intelligence quotient(IQ) ratio\> 34 (mild and moderate severe intellectual disability according to the International Statistical Classification of Diseases and Related Health Problems, ICD-10, criteria).
- Subjects without dementia: Absence of loss of cognitive functions (demonstrated by the longitudinal administration of neuropsychological tests and verified by family members)
- Absence of psychiatric comorbidity
You may not qualify if:
- Severe intellectual disability (due to limitations in cognitive tests)
- Presence of psychiatric pathology, unstable disease, cardiac or respiratory failure.
- Intake of psychoactive drugs in the three months prior to the study.
- Patients diagnosed with OSA, undergoing treatment with CPAP.
- Subjects with an Epworth Sleep Scale score \> 12
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Multidisciplinary Sleep Unit. Hospital de la Santa Creu i Sant Pau
Barcelona, 08025, Spain
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 28, 2019
First Posted
December 13, 2019
Study Start
December 1, 2019
Primary Completion
November 1, 2020
Study Completion
November 1, 2021
Last Updated
December 17, 2019
Record last verified: 2019-12